Literature DB >> 26564657

Low-dose acetylsalicylic acid for primary prevention of cardiovascular disease: Do not misinterpret the recommendations.

Christine Truong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26564657      PMCID： PMC4642907     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Cardiology patient page: Aspirin.

Authors:  Jeremy S Paikin; John W Eikelboom
Journal:  Circulation       Date:  2012-03-13       Impact factor: 29.690

2.  Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

Authors:  Yasuo Ikeda; Kazuyuki Shimada; Tamio Teramoto; Shinichiro Uchiyama; Tsutomu Yamazaki; Shinichi Oikawa; Masahiro Sugawara; Katsuyuki Ando; Mitsuru Murata; Kenji Yokoyama; Naoki Ishizuka
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

3.  The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

Authors:  Alan D Bell; André Roussin; Raymond Cartier; Wee Shian Chan; James D Douketis; Anil Gupta; Maria E Kraw; Thomas F Lindsay; Michael P Love; Neesh Pannu; Rémi Rabasa-Lhoret; Ashfaq Shuaib; Philip Teal; Pierre Théroux; Alexander G G Turpie; Robert C Welsh; Jean-François Tanguay
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

4.  Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

Authors:  Alice Y Y Cheng
Journal:  Can J Diabetes       Date:  2013-03-26       Impact factor: 4.190

Review 5.  The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery disease.

Authors:  Marzia Lotrionte; Giuseppe Gl Biondi-Zoccai
Journal:  Curr Opin Cardiol       Date:  2008-09       Impact factor: 2.161

6.  Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Authors:  Michael Pignone; Mark J Alberts; John A Colwell; Mary Cushman; Silvio E Inzucchi; Debabrata Mukherjee; Robert S Rosenson; Craig D Williams; Peter W Wilson; M Sue Kirkman
Journal:  Diabetes Care       Date:  2010-06       Impact factor: 19.112

Review 7.  Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.

Authors:  Jean-François Tanguay; Alan D Bell; Margaret L Ackman; Robert D C Bauer; Raymond Cartier; Wee-Shian Chan; James Douketis; André Roussin; Gregory Schnell; Subodh Verma; Graham Wong; Shamir R Mehta
Journal:  Can J Cardiol       Date:  2013-08-23       Impact factor: 5.223

8.  Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.

Authors:  Luis A García Rodríguez; Lucía Cea-Soriano; Elisa Martín-Merino; Saga Johansson
Journal:  BMJ       Date:  2011-07-19
  8 in total
  3 in total

1.  Different perspective on ASA use.

Authors:  Jeff Nagge; Jillian Bauer
Journal:  Can Fam Physician       Date:  2016-01       Impact factor: 3.275

2.  Use of low-dose acetylsalicylic acid for cardiovascular disease prevention: A practical, stepwise approach for pharmacists.

Authors:  Arden R Barry; William M Semchuk; Ann Thompson; Marlys H LeBras; Sheri L Koshman
Journal:  Can Pharm J (Ott)       Date:  2020-03-19

3.  Update on acetylsalicylic acid for primary prevention of cardiovascular disease: Not initiating is not the same thing as discontinuing.

Authors:  Christine Truong
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.